RECURRENT CUTANEOUS MELANOMA
Clinical trials for RECURRENT CUTANEOUS MELANOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT CUTANEOUS MELANOMA trials appear
Sign up with your email to follow new studies for RECURRENT CUTANEOUS MELANOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Major trial tests new drug to stop deadly skin Cancer's return
Disease control OngoingThis large study is testing if a newer immunotherapy drug, pembrolizumab, is better at preventing melanoma from coming back after surgery than the current standard treatments. It involves over 1,300 patients with stage III or IV melanoma who have had their cancer surgically remov…
Matched conditions: RECURRENT CUTANEOUS MELANOMA
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
New drug tested as last hope for Tough-to-Treat skin cancer
Disease control OngoingThis study is testing whether the drug ibrutinib can help control advanced skin melanoma that has continued to grow despite previous standard treatments. It will involve about 18 adults whose cancer has spread and is no longer responding to immunotherapy or other targeted drugs. …
Matched conditions: RECURRENT CUTANEOUS MELANOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
Boosting the immune system to fight skin cancer before surgery
Disease control OngoingThis study is testing if a new drug combination works better than a standard drug alone to shrink melanoma tumors before surgery. It involves 60 adults with stage III melanoma that can be surgically removed. The goal is to see if the combination helps the immune system attack the…
Matched conditions: RECURRENT CUTANEOUS MELANOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC